Clinical Trials Search | Clareo Health

Showing 1-2 of 2 trials

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

NCT06954090

Title: Body fluid proteome SIGnatures for persoNALised intervention to prevent cardiovascular and renal complications in diabetes. Aim: To explore the feasibility of using urinary proteomic risk scores in clinical practice to identify patients at risk of developing end organ damage and identify which patients should receive additional renocardiovascular protective treatment.

Type 2 DMType 2 DM /Diabetic NephropathyAlbuminuria

Steno Diabetes Center Copenhagen50 participantsStarted Nov 2025

Herlev, Hajdú-Bihar, Denmark

UNKNOWN

CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy

NCT05681286

we aimed to compare C-reactive protein to serum albumin ( CAR) level of the T2DM patients with DN to those T2DM without DN

Type 2 DM /Diabetic Nephropathy

Assiut University70 participantsStarted Aug 2023

Data from ClinicalTrials.govTerms

Filters

Filters

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy